Selection of both normal and bleeding patients is indicated before desmopressin administration.
Girolami
Antonio
A
Vettore
Silvia
S
Fabris
Fabrizio
F
D002539:Cerebral Arterial Diseases / Q000139:chemically induced*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D003894:Deamino Arginine Vasopressin / Q000009:adverse effects*; D005260:Female; D006490:Hemostatics / Q000009:adverse effects; D006801:Humans; D020767:Intracranial Thrombosis / Q000139:chemically induced*; D018579:Patient Selection; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D014842:von Willebrand Diseases / Q000188:drug therapy
D003277:Contraceptives, Oral, Combined; D006490:Hemostatics; D003894:Deamino Arginine Vasopressin